The influence of smoking and parity on serum markers for Down's syndrome screening

被引:15
|
作者
Tislaric, D
Brajenovic-Milic, B
Ristic, S
Latin, V
Zuvic-Butorac, M
Bacic, J
Petek, M
Kapovic, M
机构
[1] Univ Hosp Sestre Milosrdnice, Dept Endocrinol, Zagreb 10000, Croatia
[2] Univ Rijeka, Sch Med, Dept Biol, Zagreb, Croatia
[3] Outpatient Clin VILI, Zagreb, Croatia
[4] Univ Rijeka, Sch Med, Dept Phys, Rijeka, Croatia
[5] Publ Hlth Ctr, Rijeka, Croatia
关键词
Down's syndrome screening; alpha-fetoprotein; free beta-hCG; smoking; parity;
D O I
10.1159/000047999
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To evaluate the impact of smoking and number of previous births on maternal serum levels of a-fetoprotein and free beta-subunit of human chorionic gonadotropin (free beta-hCG). Methods: The study included 13,252 completed unaffected singleton pregnancies that proceeded beyond 37 weeks' gestation and resulted with a birth of healthy child. Smoking status of mothers and data concerning gravidity and parity were collected at the sampling date. Serum markers were measured between 13 and 22 gestational weeks, corrected for maternal weight, and converted to multiples of median (MoM) for unaffected pregnancy of the corresponding gestational age. Median MoM values for both markers were examined in relation to both: smoking habits and number of previous births. Results: Smokers had significantly decreased free beta-hCG MoM values compared to nonsmokers (p<0.001). The median levels showed a negative relationship with the number of previous births. The significance of a decreasing trend was proved, both in smokers:(p<0.001) and nonsmokers (p<0.001). The median maternal serum α-fetoprotein MoM values did not show any significant dependence, neither with regard to smoking (p=0.65) nor with regard to parity (p=0.07). Conclusions: The recommendable adjustment of serum markers to smoking habits, especially concerning the free β-hCG levels, would be worthwhile. The evidence of the coexisting influence of parity on serum levels of free β-hCG, both in smokers and nonsmokers, should perhaps be a,stimulus for reconsideration of which corrections the screening performance is dependent on. Copyright (C) 2002 S. Karger AG, Basel.
引用
收藏
页码:17 / 21
页数:5
相关论文
共 50 条
  • [21] Parity and the risk of Down's syndrome
    Doria-Rose, VP
    Kim, HS
    Augustine, ETJ
    Edwards, KL
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2003, 158 (06) : 503 - 508
  • [22] First trimester serum tests for Down's syndrome screening
    Alldred, S. Kate
    Takwoingi, Yemisi
    Guo, Boliang
    Pennant, Mary
    Deeks, Jonathan J.
    Neilson, James P.
    Alfirevic, Zarko
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (11):
  • [23] Serum screening uptake and attitudes towards Down's syndrome
    Bryant, LD
    Green, JM
    Hewison, J
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 : 309 - 309
  • [24] Maternal serum screening for Down's syndrome on population basis
    Salonen, R
    Turpeinen, U
    Kurki, L
    Lappalainen, M
    Ammala, P
    Hiilesmaa, V
    Teramo, K
    vonKoskull, H
    Gahmberg, N
    Stenman, UH
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1997, 76 (09) : 817 - 821
  • [25] Ethnic differences in the outcome of serum screening for Down's syndrome
    Gilbert, L
    Nicholl, J
    Alex, S
    Smethurst, I
    Mander, A
    Andrews, A
    Patrick, J
    BRITISH MEDICAL JOURNAL, 1996, 312 (7023): : 94 - 95
  • [26] Second trimester serum tests for Down's Syndrome screening
    Alldred, S. K.
    Deeks, J. J.
    Guo, B.
    Neilson, J. P.
    Alfirevic, Z.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (06):
  • [27] Screening for Down's syndrome in early and late first and second trimester using six maternal serum markers
    Christiansen, M
    Larsen, SO
    Oxvig, C
    Qin, QP
    Wagner, JM
    Overgaard, MT
    Gleich, GJ
    Sottrup-Jensen, L
    Norgaard-Pedersen, B
    CLINICAL GENETICS, 2004, 65 (01) : 11 - 16
  • [28] Serum markers for Down's syndrome in women who have had in vitro fertilisation:: implications for antenatal screening
    Wald, NJ
    White, N
    Morris, JK
    Huttly, WJ
    Canick, JA
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1999, 106 (12): : 1304 - 1306
  • [29] Prenatal screening for Down's syndrome with maternal markers: Tunisian experience
    Ferchichi, S.
    Chahed, H.
    Jaidane, Z.
    Chaabouni, Y.
    Saafi, N.
    Limem, H. B.
    Sakouhi, M.
    Bernard, M.
    Khairi, H.
    Laradi, S.
    Miled, A.
    IMMUNO-ANALYSE & BIOLOGIE SPECIALISEE, 2010, 25 (04): : 205 - 211
  • [30] Influence of smoking habits on Down's syndrome risk evaluation at mid-trimester through biochemical screening
    Perona, M
    Mancini, G
    Dall'Amico, D
    Guaraldo, V
    Carbonara, A
    INTERNATIONAL JOURNAL OF CLINICAL & LABORATORY RESEARCH, 1998, 28 (03): : 179 - 182